Literature DB >> 16125285

Replication and immunoactivity of the recombinant Peromyscus maniculatus cytomegalovirus expressing hantavirus G1 glycoprotein in vivo and in vitro.

Albert A Rizvanov1, Svetlana F Khaiboullina, Albert G M van Geelen, Stephen C St Jeor.   

Abstract

Previously, we have shown that CMV isolated from deer mouse could be used in vivo and in vitro to express Sin Nombre virus (SNV) glycoprotein G1 in deer mice [Rizvanov AA, van Geelen AG, Morzunov S, et al. Generation of a recombinant cytomegalovirus for expression of a hantavirus glycoprotein. J.Virol. 2003;77(22):12203-10]. In this report, we further characterize replication of wild-type (wt) and recombinant Peromyscus CMV (PCMV) in vivo and in vitro using realtime PCR, and infectious center assays. Our findings indicate that both wt PCMV and recombinant PCMV establish persistent infections in P. maniculatus. In addition, we demonstrated that gamma irradiation of PCMV infected mice resulted in reactivation of recombinant PCMV in persistently infected mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16125285     DOI: 10.1016/j.vaccine.2005.07.070

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Eradicating infectious disease using weakly transmissible vaccines.

Authors:  Scott L Nuismer; Benjamin M Althouse; Ryan May; James J Bull; Sean P Stromberg; Rustom Antia
Journal:  Proc Biol Sci       Date:  2016-10-26       Impact factor: 5.349

2.  Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.

Authors:  Kyle S Brown; David Safronetz; Andrea Marzi; Hideki Ebihara; Heinz Feldmann
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

Review 3.  Vaccine vectors: the bright side of cytomegalovirus.

Authors:  Andrea C Méndez; Cristina Rodríguez-Rojas; Margarita Del Val
Journal:  Med Microbiol Immunol       Date:  2019-03-21       Impact factor: 3.402

4.  Evaluating the promise of recombinant transmissible vaccines.

Authors:  Andrew J Basinski; Tanner J Varrelman; Mark W Smithson; Ryan H May; Christopher H Remien; Scott L Nuismer
Journal:  Vaccine       Date:  2017-12-24       Impact factor: 3.641

5.  Transmissible vaccines in heterogeneous populations: Implications for vaccine design.

Authors:  Tanner J Varrelman; Andrew J Basinski; Christopher H Remien; Scott L Nuismer
Journal:  One Health       Date:  2019-02-20

Review 6.  From Vaccine Vector to Oncomodulation: Understanding the Complex Interplay between CMV and Cancer.

Authors:  Nicole A Wilski; Christopher M Snyder
Journal:  Vaccines (Basel)       Date:  2019-07-09

Review 7.  Self-disseminating vaccines for emerging infectious diseases.

Authors:  Aisling A Murphy; Alec J Redwood; Michael A Jarvis
Journal:  Expert Rev Vaccines       Date:  2015-11-02       Impact factor: 5.217

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.